Honda is recalling 303,700 2023 and 2024 Accords and HR-Vs because of a defect that could stop some front seat belts in the vehicles from tightening properly in a crash.
The automaker is recalling Accords built between Oct. 4, 2022, and Oct. 14, 2023, as well as HR-Vs made between April 26, 2022, and Oct. 14, 2023, it said in a filing last week with the National Highway Traffic Safety Administration. All of the vehicles being recalled are gas-powered, rather than hybrids.
Honda said the front seat belt pretensioners in a fraction of those vehicles were assembled without a rivet that secures the quick connector and wire plate. It said the installation of that rivet was skipped during assembly but did not explain why or how.
Without that rivet, the seat belt will not tighten to properly restrain occupants and get their bodies into a safe position in the event of a crash, making harm more likely.
The company estimated that 1% of the vehicles being recalled are defective. It said it has had seven warranty claims related to the problem and no reports of injuries or deaths.
Honda said in its filing that it received its first complaint about the problem May 23. On Sept. 20, it received the affected parts and began to investigate, and on Nov. 16 it identified a defect that necessitated the recall.
Marley Jay
Marley Jay is a business news reporter for NBC News Digital.
News Related-
AI chip boom fuels MediaTek’s 40% rally, beating Qualcomm and peers
-
Singtel is next S’pore stock to be traded on Thailand bourse under depository receipt linkage scheme
-
Chinese Swimming Club renews lease of Amber Road site for another 30 years
-
Cyber Monday forecast boosted after record online holiday sales
-
WealthBT Podcast: Powering up philanthropy for climate goals
-
US stocks pull back after weeks of gains
-
Former Binance CEO Zhao Changpeng must stay in US for now, judge says
-
Sports Illustrated scrubs AI-generated content after being called out for using deep fakes
-
Climate finance: UK-based standard setter VCMI’s introduction of flexibility to carbon credits market could unleash demand, much-needed investment
-
Fast-fashion giant Shein could be next blockbuster IPO after filing to go public: report
-
New York's cannabis board votes to settle lawsuits that have stalled legal dispensaries
-
CK Hutchison-backed HutchMed eyes global expansion after FDA approval for novel cancer drug
-
Cyber Monday sales set to reach $12.4 billion thanks to deal-hunters
-
Texas' new power grid problem